However, the affinity of the bi-specific antibody is limited to only one type of inhibitor and does not neutralize the activity of other inhibitors, e.g., factor H, which is present in serum in micromolar concentration and, when hijacked by tumor cells, contributes to anti-CD20 mAb resistance [6]. Here, CFH is linked to neoplasm.